OSTX OS Therapies: Company Short-Term Debts

Symbol and logo of brand OS Therapies Incorporated (OSTX)

OS Therapies Incorporated (OSTX) is developing immunotherapy to combat rare pediatric bone tumors. The short-term debt portfolio reflects obligations due within one year, where the current mark is 0.00. The growth model relies on patents, which will enable the scaling of drug production via outsourcing without capital expenditures. The current success of the business depends on the outcomes of osteosarcoma vaccine trials.

OSTX OS Therapies Inc. Company Short-Term Loans and Borrowings (08/02/2024 - 10/31/2026)

OSTX (OS Therapies, Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price OS Therapies|OSTX - Consensus Target
- company stock capitalization data:
Market Capitalization OS Therapies Incorporated|OSTX - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share OS Therapies|OSTX - Accounting Value of Company|Market Cap to Net Assets Ratio ostherapies.com|OSTX - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital OS Therapies Incorporated|OSTX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio OS Therapies Incorporated|OSTX - Company Aggregate Debts|Debt to Book Capitalization Ratio OS Therapies Incorporated|OSTX - Company Long-Term Loans and Borrowings|Company Short-Term Debts OS Therapies|Quick Liquidity ostherapies.com
- earnings and multiples data:
OSTX - Company Net Income
Analysis of all company metrics:OSTX - OS Therapies
Manufactured products of ostherapies.com

For OS Therapies Incorporated (OSTX), whose valuation is driven exclusively by the outcomes of clinical trials for osteosarcoma drugs, managing short-term financing is critical. An analysis of the current debt obligations chart allows for the tracking of debt maturing within one year, which reveals risks of liquidity gaps and determines overall capital solvency amidst isolation from macroeconomic factors.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debt Citius Oncology, Inc. (CTOR)|HURA - Short-Term Debt|Company Short-Term Debt Protara Therapeutics, Inc. TARA|Short-Term Debt Volume Fate Therapeutics Inc (FATE)|WHWK: Company Current Liabilities|Company Short-Term Loans and Borrowings TCRX (TScan Therapeutics)|CSBR (championsoncology.com) - Company Current Liabilities|XBIT: Amount of Current Liabilities|CVM (CEL-SCI Corp.) - Company Short-Term Debts|RADX: Company Short-Term Loans and Borrowings|Company Short-Term Debts ARTV|ANL - Short-Term Debt|Company Short-Term Debt Veru Inc. VERU|Company Short-Term Loans and Borrowings TPST|Xilio - Company Short-Term Debts|RENB - Company Short-Term Debts|muraloncology.com (MURA) - Company Short-Term Debt|Current Liabilities KAPA (Kairos Pharma)|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|CytoMed (GDTC) - Short-Term Debt Volume|Company Short-Term Debts CRIS|APLM - Short-Term Debt|Company Short-Term Debt Tharimmune Corp THAR|Short-Term Debt Volume Advanced Biomed Inc. (ADVB)|GNPX: Company Current Liabilities|Company Short-Term Loans and Borrowings CLDI (Calidi Biotherapeutics)|SBFM: Company Short-Term Debts|XBIO - Short-Term Debt Volume|Company Short-Term Debt Salarius|Company Short-Term Indebtedness PPBT (Kitov Pharma)|Company Short-Term Debts AONC|Company Current Liabilities beigene.com BGNE|Company Short-Term Debt Checkpoint Therapeutics, Inc. CKPT|Elevation Oncology Inc. (ELEV) - Short-Term Debt|ICAD - Company Short-Term Debt|Company Short-Term Loans and Borrowings IKNA (Ikena Oncology, Inc.)|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|Current Liabilities VIRX (Viracta Therapeutics, Inc.)|Company Short-Term Debt MorphoSys|Short-Term Debt NAYA Biosciences Inc NAYA|Company Short-Term Debt Ascentage Pharma Group Ltd (AAPGV)